109 related articles for article (PubMed ID: 16570574)
21. Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues.
Geers C; Colin IM; Gérard AC
Thyroid; 2011 Dec; 21(12):1323-30. PubMed ID: 22066479
[TBL] [Abstract][Full Text] [Related]
22. Interpretation of RET immunostaining in follicular lesions of the thyroid.
Cerilli LA; Mills SE; Rumpel CA; Dudley TH; Moskaluk CA
Am J Clin Pathol; 2002 Aug; 118(2):186-93. PubMed ID: 12162676
[TBL] [Abstract][Full Text] [Related]
23. [Pathological study on the expression of cell adhesion molecules and metastasis suppressor gene in thyroid follicular carcinoma and papillary carcinoma].
Liu Y; Jiang C; Tan Y
Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):322-6. PubMed ID: 12417089
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase expression is increased in papillary thyroid carcinoma of children and young adults.
Patel A; Fenton C; Ramirez R; Dinauer CA; Tuttle RM; Nikiforov YE; Gary FL
Front Biosci; 2000 Mar; 5():A1-9. PubMed ID: 10702379
[TBL] [Abstract][Full Text] [Related]
25. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
26. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
[TBL] [Abstract][Full Text] [Related]
27. Expression of vascular endothelial growth factor receptors in bovine cystic follicles.
Isobe N; Kitabayashi M; Yoshimura Y
Reprod Domest Anim; 2008 Jun; 43(3):267-271. PubMed ID: 18042207
[TBL] [Abstract][Full Text] [Related]
28. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
30. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
31. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
[TBL] [Abstract][Full Text] [Related]
33. CD117: a novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2014 Aug; 122(8):596-603. PubMed ID: 24920192
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
[TBL] [Abstract][Full Text] [Related]
35. Activin A and activin receptors in thyroid cancer.
Schulte KM; Jonas C; Krebs R; Röher HD
Thyroid; 2001 Jan; 11(1):3-14. PubMed ID: 11272093
[TBL] [Abstract][Full Text] [Related]
36. The Role of Claudin-1 Expression in Follicular and Papillary Thyroid Neoplasm.
Miskad UA; Aswidah A; Dahlan H; Ikram D; Cangara MH; Djimahit T; Kaelan C
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4023-4027. PubMed ID: 36579982
[TBL] [Abstract][Full Text] [Related]
37. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma.
Lo CY; Lam KY; Leung PP; Luk JM
Eur J Endocrinol; 2005 Apr; 152(4):545-50. PubMed ID: 15817909
[TBL] [Abstract][Full Text] [Related]
39. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.
de Souza Meyer EL; Dora JM; Wagner MS; Maia AL
Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.
Witte J; Lehmann S; Wulfert M; Yang Q; Röher HD
World J Surg; 2007 Jan; 31(1):51-9. PubMed ID: 17171498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
